Silver Sword capsules — Class I drug recall D-1170-2014
Terminated recall by Fabscout Entertainment, Inc, reported 2014-03-26, distributed nationwide. Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the produc
| Recall number | D-1170-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Fabscout Entertainment, Inc, Ft Lauderdale, FL, United States |
| Recall initiated | 2013-06-27 |
| Classified | 2014-03-20 |
| Reported by FDA | 2014-03-26 |
| Terminated | 2019-10-02 |
| Distributed | Nationwide (US) |
| Countries outside the US | FR |
| Reason classes | undeclared allergen, unapproved product |
Product
Silver Sword capsules, 180 mg, 16-count clamshell tin, UPC 1 234658 970128 12345 (labeling is in foreign language)
Reason for recall
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1170-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.